Immunoconjugate Therapy of Hematologic Malignancies

Immunoconjugate Therapy of Hematologic Malignancies
Author: Steven T. Rosen
Publisher: Springer Science & Business Media
Total Pages: 293
Release: 2012-12-06
Genre: Medical
ISBN: 1461530768

The hybridoma technique for producing monoclonal antibodies, developed by Drs. Kohler and Millstein in 1975, revolutionized the field of tumor immunology. It is now clear that there are antigens associated with or restricted to human neoplasms that have biologic significance. Monoclonal antibodies have already been demonstrated to have great immunodiagnostic value and it is anticipated that they will become a component of our therapeutic armamentarium. Most investigators in the field, however, feel that the true potential of monoclonal antibodies in cancer therapy remains to be determined. Clearly the most encouraging results have been witnessed in the treatment of hematologic malignancies. This volume of CANCER TREATMENT AND RESEARCH explores the current state of the art of immunoconjugate therapy of hematologic malignancies. Immunoconjugate Therapy of Hematologic Malignancies provides an update of a rapidly advancing field. The preliminary experience of a number of investigators suggests a role for targeted therapy in the treatment of hematologic malignancies. At the present time, immunoconjugates have, in most instances, been reserved for patients with advanced refractory disease. However, it is anticipated in the future that these reagents will be utilized as a complement to traditional therapy or as post-remission consolidation in patients with minimal residual disease. The obstacles have been defined; solutions will require further research and creative imagination.

Pediatric Nuclear Medicine

Pediatric Nuclear Medicine
Author: S. Ted Treves
Publisher: Springer Science & Business Media
Total Pages: 617
Release: 2013-04-17
Genre: Medical
ISBN: 1475742053

The 3rd edition of this classic – considered the standard in the field - reflects the latest advances in PET, SPECT, and oncology. Updated to incorporate cutting-edge diagnostic techniques, it serves as a bedrock resource for physicians whose nuclear medicine practices include children and provides a vast amount of background material for residents in training. The new edition retains the fundamental standard of excellence that earned its predecessors such a distinguished reputation. It has been thoroughly updated to incorporate cutting-edge diagnostic techniques. Pediatric Nuclear Medicine/PET, Third Edition is an indispensable resource for physicians whose practices include children and provides a vast amount of background material for residents in training.

Safety and efficacy of radiopharmaceuticals 1987

Safety and efficacy of radiopharmaceuticals 1987
Author: Knud Kristensen
Publisher: Springer Science & Business Media
Total Pages: 370
Release: 2012-12-06
Genre: Medical
ISBN: 9400933754

Safety and Efficacy of Radiopharmaceuticals was established as a very important and comprehensive subject at the First Europe an Symposium on Radiopharmacy and Radiopharmaceuticals in Denmark in 1983. The interest in this subject has grown considerably since then due to the growing interest among national authorities to deal with radiopharmaceuticals. The introduction in recent years of nuclear medicine techniques based on radioactive labelled cells and on monoclonal antibodies has stressed the importance of a well functioning approval system for the clinical trial and use of new radiopharmaceuticals. The process of transferring the experience from the non radioactive drug field into the area of radiopharmaceuticals is still ongoing. International organisations such as the World Health Organisa tion is also including this into their quality assurance programme from both the radiopharmaceutical and the radiation hygiene point of view. In order to give an up-to date survey of these areas, experts were invited to prepare review papers under the following headings: Safety and Efficacy of Radiophar maceuticals with Emphasis on Biological Products, Radiophar macy/Radiation Hygiene, Legal Aspects of the Introduction of New Radiopharmaceuticals and some selected aspects of Good Radiopharmacy Practice.

Cardiovascular Nuclear Medicine and MRI

Cardiovascular Nuclear Medicine and MRI
Author: Johan H. C. Reiber
Publisher: Springer Science & Business Media
Total Pages: 409
Release: 2012-12-06
Genre: Medical
ISBN: 9401126666

In recent years there have been major advances in the fields of cardiovascular nuclear medicine and cardiac magnetic resonance imaging. In nuclear cardiology more adequate tomographic systems have been designed for routine cardiac use, as well as new or improved quantitative analytic software packages both for planar and tomographic studies implemented on modern state-of-the-art workstations. In addition, artificial intelligence techniques are being applied to these images in attempts to interpret the nuclear studies in a more objective and reproducible manner. Various new radiotracers have been developed, such as antimyosin, labeled isonitriles, metabolic compounds, etc. Furthermore, alternative stress testing with dipyridamole and dobutamine has received much attention in clinical cardiac practice. Magnetic resonance imaging is a relative newcomer in cardiology and has already shown its merits, not only for anatomical information but increasingly for the functional aspects of cardiac performance. This book covers almost every aspect of quantitative cardiovascular nuclear medicine and magnetic resonance imaging. It will assist the nuclear medicine physician, the radiologist, the physicist/image processing specialist and the clinical cardiologist in understanding the nuclear medicine techniques used in cardiovascular medicine, and in increasing our knowledge of cardiac magnetic resonance imaging.

A Review of the Draft Report of the NCI-CDC Working Group to Revise the 1985 Radioepidemiological Tables

A Review of the Draft Report of the NCI-CDC Working Group to Revise the 1985 Radioepidemiological Tables
Author: National Academy of Sciences
Publisher: National Academies Press
Total Pages: 63
Release: 2001-01-22
Genre: Science
ISBN: 0309072506

The National Research Council was asked by the Centers for Disease Control and Prevention (CDC) to review the draft report of the National Cancer Institute (NCI)-CDC's working group charged with revising the 1985 radioepidemiological tables. To this end, a subcommittee was formed consisting of members of the Council's Committee on an Assessment of the Centers for Disease Control and Prevention Radiation Programs and other experts. The original tables were mandated under Public Law 97-414 (the "Orphan Drug Act") and were intended to provide a means of estimating the probability that a person who developed any of a series of radiation-related cancers, developed the cancer as a result of a specific radiation dose received before the onset of the cancer. The mandate included a provision for periodic updating of the tables. The motivation for the current revision reflects the availability of new data, especially on cancer incidence, and new methods of analysis, and the need for a more thorough treatment of uncertainty in the estimates than was attempted in the original tables.